NCT02207881View on ClinicalTrials.gov

A Double-Blind, Randomized, Placebo-Controlled Study of Topical VDO for the Treatment of Herpes Simplex Labialis

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Herpes Labialis

Interventions

DRUG

VDO gel

DRUG

placebo

matching placebo gel

Trial Locations (1)

Unknown

Changhua Christian Hospital, Changhua

All Listed Sponsors

collaborator

Changhua Christian Hospital

OTHER

lead

Yung Shin Pharm. Ind. Co., Ltd.

INDUSTRY

NCT02207881 - A Double-Blind, Randomized, Placebo-Controlled Study of Topical VDO for the Treatment of Herpes Simplex Labialis | Biotech Hunter | Biotech Hunter